Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2025-12985
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
License Service: Privilege escalation vulnerability
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM Licensing Operator incorrectly assigns privileges to security critical files which could allow a local root escalation inside a container running the IBM Licensing Operator image.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Source: NVD (National Vulnerability Database)
Vulnerability Type
关键资源的不正确权限授予
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM Licensing Operator 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM Licensing Operator是美国国际商业机器(IBM)公司的一个自动收集管理数据的组件。 IBM Licensing Operator存在安全漏洞,该漏洞源于权限分配不当,可能导致在运行IBM Licensing Operator镜像的容器内本地权限提升。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
IBMIBM Licensing Operator 9.0.0 cpe:2.3:a:ibm:license_metric_tool:9.0.0:*:*:*:*:*:*:*
II. Public POCs for CVE-2025-12985
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2025-12985
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2025-12985

No comments yet


Leave a comment